Medications

Critical heart drug too pricey for some Medicare patients

An effective drug to treat chronic heart failure may cost too much for senior citizens with a standard Medicare Part D drug plan, said a study co-authored by a John A. Burns School of Medicine (JABSOM) researcher at the University ...

Medications

Novartis generics unit Sandoz makes stock market debut

Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.

Medications

New anti-cholesterol drugs too expensive: report

The high price of two new anti-cholesterol drugs limits the benefits patients may see from them, according to a draft report released Wednesday by a US nonprofit examining drug cost effectiveness.

page 3 from 22